3 research outputs found
Seasonal variations of hydrographic parameters off the Sudanese coast of the Red Sea, 2009–2015
No full text© The Author(s), 2017. This article is distributed under the terms of the Creative Commons Attribution License. The definitive version was published in Regional Studies in Marine Science 18 (2018): 1-10, doi:10.1016/j.rsma.2017.12.004.The variations of temperature and salinity in the Sudanese coastal zone of the Red Sea are studied for the first time using measurements acquired from survey cruises during 2009–2013 and from a mooring during 2014–2015. The measurements show that temperature and salinity variability above the permanent pycnocline is dominated by seasonal signals, similar in character to seasonal temperature and salinity oscillations observed further north on the eastern side of the Red Sea. Using estimates of heat flux, circulation and horizontal temperature/salinity gradients derived from a number of sources, we determined that the observed seasonal signals of temperature and salinity are not the product of local heat and mass flux alone, but are also due to alongshore advection of waters with spatially varying temperature and salinity. As the temperature and salinity gradients, characterized by warmer and less saline water to the south, exhibit little seasonal variation, the seasonal salinity and temperature variations are closely linked to an observed seasonal oscillation in the along-shore flow, which also has a mean northward component. We find that the inclusion of the advection terms in the heat and mass balance has two principal effects on the computed temperature and salinity series. One is that the steady influx of warmer and less saline water from the south counteracts the long-term trend of declining temperatures and rising salinities computed with only the local surface flux terms, and produces a long-term steady state in temperature and salinity. The second effect is produced by the seasonal alongshore velocity oscillation and most profoundly affects the computed salinity, which shows no seasonal signal without the inclusion of the advective term. In both the observations and computed results, the seasonal salinity signal lags that of temperature by roughly 3 months.The SPS surveys were funded by the Norwegian Norad’s Program for Master Studies and organized by IMR–RSU in Port Sudan. The central Red Sea mooring data were acquired as part of a WHOI–KAUST collaboration funded by Award Nos. USA00001, USA00002, and KSA00011 to the WHOI by the KAUST in the Kingdom of Saudi Arabia. The work of I. Skjelvan and A.M. Omar was partly supported by the Research Council of Norway through the MIMT Center for Research-based Innovation. This work is part of a Ph.D. project at GFI–UiB funded by the Norwegian Quota program
An extensive computational investigation of Mycobacterium tuberculosis Pantothenate Synthetase inhibitors from Diverse-lib Compounds library
No full textDATA AVAILABILITY STATEMENT :
The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.Antibiotics have played a crucial role in significantly reducing the incidence of tuberculosis (TB) infection worldwide. Even before the mid-20th century, the mortality rate of TB onset within five years was around 50 %. So, the introduction of antibiotics has changed the scenario of TB from a serious threat to a manageable one. However, the emergence of resistance to anti-TB drugs poses a significant challenge. So, to overcome this situation the therapeutic approaches and drug targets need to be reformed. This study focused on finding potential inhibitors by targeting Pantothenate Synthetase, a crucial enzyme for Mycobacterium tuberculosis (Mtb) survival, through computational drug discovery methods. Molecular docking and virtual screening were employed to identify potential inhibitors from Diverse-lib. Four compounds, namely CID2813602, 24357538, CID753354, and CID4798023, exhibited strong binding energies and stable interaction with the target protein. Further assessment of these compounds through MD simulation and Post MD simulation showed significant dynamic stability. The minimum energy transition calculated using the free energy landscape analysis of these compounds when docked with Pantothenate Synthetase confirmed the stability of each complex due to its minimum energy production. The free binding energy calculation of each complex also showed the intramolecular interaction contributes to the strong binding affinity of the compounds within the enzyme's active site clarifying their mechanisms of action. This research showcases the effectiveness of computational methods in promptly identifying potential anti-TB drugs, paving the way for future experimental validation and optimization. It holds promise for the development of new treatments targeting drug-resistant TB strains.Deanship of Scientific research at Northern Border University.https://www.chemistryselect.orghj2024School of Health Systems and Public Health (SHSPH)SDG-03:Good heatlh and well-bein
Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial.
No full textBACKGROUND: Post-partum haemorrhage is the leading cause of maternal death worldwide. Early administration of tranexamic acid reduces deaths due to bleeding in trauma patients. We aimed to assess the effects of early administration of tranexamic acid on death, hysterectomy, and other relevant outcomes in women with post-partum haemorrhage. METHODS: In this randomised, double-blind, placebo-controlled trial, we recruited women aged 16 years and older with a clinical diagnosis of post-partum haemorrhage after a vaginal birth or caesarean section from 193 hospitals in 21 countries. We randomly assigned women to receive either 1 g intravenous tranexamic acid or matching placebo in addition to usual care. If bleeding continued after 30 min, or stopped and restarted within 24 h of the first dose, a second dose of 1 g of tranexamic acid or placebo could be given. Patients were assigned by selection of a numbered treatment pack from a box containing eight numbered packs that were identical apart from the pack number. Participants, care givers, and those assessing outcomes were masked to allocation. We originally planned to enrol 15 000 women with a composite primary endpoint of death from all-causes or hysterectomy within 42 days of giving birth. However, during the trial it became apparent that the decision to conduct a hysterectomy was often made at the same time as randomisation. Although tranexamic acid could influence the risk of death in these cases, it could not affect the risk of hysterectomy. We therefore increased the sample size from 15 000 to 20 000 women in order to estimate the effect of tranexamic acid on the risk of death from post-partum haemorrhage. All analyses were done on an intention-to-treat basis. This trial is registered with ISRCTN76912190 (Dec 8, 2008); ClinicalTrials.gov, number NCT00872469; and PACTR201007000192283. FINDINGS: Between March, 2010, and April, 2016, 20 060 women were enrolled and randomly assigned to receive tranexamic acid (n=10 051) or placebo (n=10 009), of whom 10 036 and 9985, respectively, were included in the analysis. Death due to bleeding was significantly reduced in women given tranexamic acid (155 [1·5%] of 10 036 patients vs 191 [1·9%] of 9985 in the placebo group, risk ratio [RR] 0·81, 95% CI 0·65-1·00; p=0·045), especially in women given treatment within 3 h of giving birth (89 [1·2%] in the tranexamic acid group vs 127 [1·7%] in the placebo group, RR 0·69, 95% CI 0·52-0·91; p=0·008). All other causes of death did not differ significantly by group. Hysterectomy was not reduced with tranexamic acid (358 [3·6%] patients in the tranexamic acid group vs 351 [3·5%] in the placebo group, RR 1·02, 95% CI 0·88-1·07; p=0·84). The composite primary endpoint of death from all causes or hysterectomy was not reduced with tranexamic acid (534 [5·3%] deaths or hysterectomies in the tranexamic acid group vs 546 [5·5%] in the placebo group, RR 0·97, 95% CI 0·87-1·09; p=0·65). Adverse events (including thromboembolic events) did not differ significantly in the tranexamic acid versus placebo group. INTERPRETATION: Tranexamic acid reduces death due to bleeding in women with post-partum haemorrhage with no adverse effects. When used as a treatment for postpartum haemorrhage, tranexamic acid should be given as soon as possible after bleeding onset. FUNDING: London School of Hygiene & Tropical Medicine, Pfizer, UK Department of Health, Wellcome Trust, and Bill & Melinda Gates Foundation
